Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


OTCPK:ATBPF - Post by User

Comment by mstrmndon Mar 11, 2021 9:00pm
147 Views
Post# 32782522

RE:RE:RE:RE:RE:RE:Email Antibe and Demand CEO be Fired!!

RE:RE:RE:RE:RE:RE:Email Antibe and Demand CEO be Fired!!I know for a fact these guys intentionally jumbled the words on 2b release to drive down...why would they do that??  Well you saw who they are in bed with that cashed in...I was listening to the conference call to clarify the ambuity for 2b results but by then the damage was already done, as planned...it is what it is...

It's these types of things...

Marky1 wrote: Great comments Arbour and Stoxx...Mastermind, I understand what you are saying, don't agree with your points but respect your right to make them

Dan is the man who
1 Hired Don Haut 
2 Hired Joe Stauffer
3) Hired Stern IR
4) Knows the Patent Laws, how fro put together a viable contract
5) Fully understands the science of our H2S products, even though he doesn't have a science background 
6)Whis is fully invested, with his entire retirement money tied up with this company.
In summary, we have a man with knowledge in science, in business, in legal matters. I'm glad that we have him!
Patience mes amis! Our bright day is coming !
Merci
Jean Marc


<< Previous
Bullboard Posts
Next >>